META, a collaborative network of manufacturing businesses and researchers, today announced a collaborative project between Hospira, GlaxoSmithKline and CSL to generate a targeted 3% productivity boost with an estimated return on investment of up to $2.4 million at Australain pharmaceutical sites.
Led by GSK, META has assembled to benefit from the business optimisation expertise of research partner University of Melbourne.
“This is META’s first productivity focused manufacturing project identified by the pharmaceutical industry, to ensure benefits from the supply-chain optimisation expertise can be leveraged to deliver major productivity improvements across a number of Australian pharmaceutical sites,” says Zoran Angelkovski, Managing Director of META.
“The unique part of the project is the methodology will be shared amongst multiple pharmaceutical companies to create an exponential benefit for the industry,” he says.
Hospira’s Mulgrave site in Victoria is the first location to engage in the project, which will ultimately achieve increases in cost competitiveness and optimisation of its site manufacturing process.
Research partner, the University of Melbourne plays a pivotal role in the project by providing a team of post-doctoral experts to work side by side with each company to apply world-class optimisation methods to the factory.
“University of Melbourne have had a strong academic focus on applied research and we are committed to seeing our academics work directly with industry to build strong and world-class standards to increase the productivity of Australian manufacturing sites,” says Associate Professor Prakash Singh of University of Melbourne.